Hemispherx Biopharma, Inc. (Amex: HEB) announced that the research group headed by Dr. H. Hasegawa, Chief, Laboratory of Mucosal Vaccine ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE